Hepatitis C News

Simplifying the hepatitis C virus treatment process is essential to improving care among vulnerable populations, particularly people who inject drugs, according to experts.

The COVID-19 pandemic has had a significant impact on medicine in the past 2-plus years.

Transplanting kidneys from donors who have the hepatitis C virus into patients who are HCV-negative is not associated with increased risk for early graft failure, according to a presentation at the American Transplant Congress.

Why is the patient receiving levofloxacin?

There were few incident hepatitis C virus infections recorded among gay and bisexual men participating in an HIV PrEP rollout study in Australia, researchers reported.

A rapid treatment model that included a 7-day starter pack of medication significantly increased hepatitis C cure rates among young people who inject drugs, according to a small study.

With the CDC suggesting that adenovirus should be considered in diagnosis of acute hepatitis in children, amidst a possible outbreak of cases in Europe and the U.S., some pediatricians are wondering what to look out for in their own practices.

The rate of vertical hepatitis C transmission is nearly 25% higher than commonly assumed, according to a reanalysis of data from more than 1,700 children born to mothers infected with the virus.

Hepatitis C virus reinfection was common in five Australian prisons, a study found — especially among injection drug users, highlighting the need for post-treatment surveillance and increased services, researchers said.

Among Medicaid beneficiaries with opioid use disorder who were diagnosed with hepatitis C virus infection during pregnancy, less than 6% received care or medication within 6 months postpartum, according to data published in Obstetrics & Gynecology.